Publicaties - Interne-geneeskunde

01jun

Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit CLL patients.

»

01mei

Platelet Transfusion before CVC Placement in Patients with Thrombocytopenia.

»

01mei

NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma.

»

01mei

High karyotypic complexity is an independent prognostic factor in patients with CLL treated with venetoclax combinations.

»

01mei

A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.

»